D.E. Shaw & Co
ORIA

D.E. Shaw & Co’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

D.E. Shaw & Co’s Portfolio ORIA Stock Details ORIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,301
Closed -$249K – 5308
2022
Q3 		$249K Buy
+25,301
New +$248K ﹤0.01% 4381

Other funds holding ORIA

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

D.E. Shaw & Co's ORIA Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q4 2022, closing a stake of 25,301 shares — an estimated $249K sold.

D.E. Shaw & Co first reported a position in ORIA in Q3 2022 and held it in 1 quarter. The position peaked at $249K in Q3 2022. 51 funds tracked by Wall St. Rank hold ORIA as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 25,301 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q4 2022, an estimated $249K.
  • D.E. Shaw & Co first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2022 and held it in 1 quarter.
  • D.E. Shaw & Co's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $249K in Q3 2022.
  • 51 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.